company background image
NOTV logo

Inotiv NasdaqCM:NOTV Stock Report

Last Price

US$10.65

Market Cap

US$274.7m

7D

10.7%

1Y

147.1%

Updated

27 Mar, 2024

Data

Company Financials +

NOTV Stock Overview

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries.

NOTV fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Inotiv, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Inotiv
Historical stock prices
Current Share PriceUS$10.65
52 Week HighUS$11.42
52 Week LowUS$1.61
Beta3.14
1 Month Change65.89%
3 Month Change197.49%
1 Year Change147.10%
3 Year Change-46.75%
5 Year Change424.63%
Change since IPO29.09%

Recent News & Updates

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Mar 19
Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Feb 13
Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Recent updates

Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Mar 19
Inotiv (NASDAQ:NOTV) Takes On Some Risk With Its Use Of Debt

Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Feb 13
Inotiv, Inc.'s (NASDAQ:NOTV) Price Is Right But Growth Is Lacking After Shares Rocket 34%

Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Dec 18
Inotiv, Inc. (NASDAQ:NOTV) Stock Rockets 61% But Many Are Still Ignoring The Company

Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Dec 13
Earnings Release: Here's Why Analysts Cut Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$12.81

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Nov 21
Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Aug 14
Is Inotiv (NASDAQ:NOTV) A Risky Investment?

Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

May 09
Is Inotiv (NASDAQ:NOTV) Using Debt In A Risky Way?

Inotiv adds 16% on settlement with U.S. over Virginia facility

Jul 18

Inotiv completes acquisition of bioanalytical company Protypia for ~$11M

Jul 07

Headwaters Capital - Inotiv: Transformation Into A Critical Full-Service Contract Research Organization

May 25

Inotiv: Leading Mid-Market CRO Ups Its Game

Feb 07

We Think Inotiv (NASDAQ:NOTV) Has A Fair Chunk Of Debt

Dec 08
We Think Inotiv (NASDAQ:NOTV) Has A Fair Chunk Of Debt

Calculating The Intrinsic Value Of Inotiv, Inc. (NASDAQ:NOTV)

Nov 17
Calculating The Intrinsic Value Of Inotiv, Inc. (NASDAQ:NOTV)

Does Inotiv (NASDAQ:NOTV) Have A Healthy Balance Sheet?

Sep 02
Does Inotiv (NASDAQ:NOTV) Have A Healthy Balance Sheet?

Inotiv reports Q2 results

May 05

Shareholder Returns

NOTVUS Life SciencesUS Market
7D10.7%-0.2%0.4%
1Y147.1%4.5%28.8%

Return vs Industry: NOTV exceeded the US Life Sciences industry which returned 3.9% over the past year.

Return vs Market: NOTV exceeded the US Market which returned 29.5% over the past year.

Price Volatility

Is NOTV's price volatile compared to industry and market?
NOTV volatility
NOTV Average Weekly Movement13.7%
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: NOTV's share price has been volatile over the past 3 months.

Volatility Over Time: NOTV's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
19742,005Bob Leasurehttps://www.inotivco.com

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company’s BASi product line.

Inotiv, Inc. Fundamentals Summary

How do Inotiv's earnings and revenue compare to its market cap?
NOTV fundamental statistics
Market capUS$274.67m
Earnings (TTM)-US$33.20m
Revenue (TTM)US$585.17m

0.5x

P/S Ratio

-8.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NOTV income statement (TTM)
RevenueUS$585.17m
Cost of RevenueUS$411.75m
Gross ProfitUS$173.43m
Other ExpensesUS$206.63m
Earnings-US$33.20m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.29
Gross Margin29.64%
Net Profit Margin-5.67%
Debt/Equity Ratio149.3%

How did NOTV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.